* Orthofix Medical Inc OFIX.OQ OFIX.O is expected to show a
rise in quarterly revenue when it reports results on August 6.
* The Lewisville, Texas-based company is expected to report a
48.0% increase in revenue to $108.205 million from $73.14
million a year ago, according to the mean estimate from 5
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for Orthofix Medical Inc is
for earnings of 11 cents per share. For the same quarter last
year, the company reported a loss of 59 cents per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 3 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in the
last three months.
* Wall Street's median 12-month price target for Orthofix
Medical Inc is $53.5, about 28.2% above its last closing price
of $38.40.
* Previous quarterly performance (using preferred earnings
measure in US dollars).
QUARTER STARMINE REFINITIV ACTUAL BEAT, SURPRI
ENDING SMARTESTIM IBES MET, SE %
ATE® ESTIMATE MISSED
Mar. 31 2021 0.01 0.02 0.17 Beat 709.5
Dec. 31 2020 0.17 0.19 0.44 Beat 126.8
Sep. 30 2020 -0.29 -0.36 0.31 Beat 185.2
Jun. 30 2020 -1.07 -1.08 -0.59 Beat 45.4
Mar. 0.07 0.06 0.09 Beat 50
31 2020
Dec. 31 2019 0.58 0.58 0.51 Missed -12.4
Sep. 30 2019 0.51 0.51 0.41 Missed -19.4
Jun. 30 2019 0.42 0.42 0.28 Missed -32.9
This summary was machine generated August 4 at 12:55 GMT. All
figures in US dollars unless otherwise stated